Crossvault Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-119,591
| Closed | -$6.22M | – | 79 |
|
|
2018
Q4 | $6.22M | Sell |
119,591
-1,001
| -0.8% | -$52K | 3.53% | 10 |
|
|
2018
Q3 | $7.49M | Sell |
120,592
-6,529
| -5% | -$405K | 3.86% | 8 |
|
|
2018
Q2 | $7.04M | Sell |
127,121
-1,550
| -1% | -$85.8K | 3.75% | 7 |
|
|
2018
Q1 | $8.14M | Buy |
128,671
+350
| +0.3% | +$22.1K | 4.63% | 4 |
|
|
2017
Q4 | $7.86M | Sell |
128,321
-225
| -0.2% | -$13.8K | 4.15% | 5 |
|
|
2017
Q3 | $8.19M | Buy |
128,546
+6,057
| +5% | +$386K | 4.7% | 4 |
|
|
2017
Q2 | $6.83M | Buy |
122,489
+275
| +0.2% | +$15.3K | 4.1% | 4 |
|
|
2017
Q1 | $6.65M | Buy |
122,214
+105
| +0.1% | +$5.71K | 4.13% | 3 |
|
|
2016
Q4 | $7.14M | Buy |
122,109
+6,535
| +6% | +$382K | 4.81% | 2 |
|
|
2016
Q3 | $6.23M | Buy |
115,574
+3,672
| +3% | +$198K | 4.34% | 3 |
|
|
2016
Q2 | $8.23M | Sell |
111,902
-25
| -0% | -$1.84K | 5.82% | 1 |
|
|
2016
Q1 | $7.15M | Sell |
111,927
-4,040
| -3% | -$258K | 5.27% | 1 |
|
|
2015
Q4 | $7.98M | Sell |
115,967
-675
| -0.6% | -$46.4K | 5.67% | 1 |
|
|
2015
Q3 | $6.91M | Buy |
116,642
+7,634
| +7% | +$452K | 5.4% | 1 |
|
|
2015
Q2 | $7.25M | Buy |
109,008
+1,375
| +1% | +$91.5K | 5.8% | 1 |
|
|
2015
Q1 | $6.94M | Buy |
107,633
+985
| +0.9% | +$63.5K | 5.55% | 1 |
|
|
2014
Q4 | $6.3M | Sell |
106,648
-705
| -0.7% | -$41.6K | 5.51% | 1 |
|
|
2014
Q3 | $5.49M | Buy |
107,353
+1,340
| +1% | +$68.6K | 5.19% | 1 |
|
|
2014
Q2 | $5.14M | Sell |
106,013
-1,375
| -1% | -$66.7K | 4.79% | 1 |
|
|
2014
Q1 | $5.58M | Buy |
107,388
+2,800
| +3% | +$145K | 5.41% | 1 |
|
|
2013
Q4 | $5.56M | Buy |
+104,588
| New | +$5.56M | 5.37% | 1 |
|